Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- Author
- TAXONERA, C1 ; ESTELLES, J1 ; GISBERT, J. P10 13 ; VERA, I11 ; MARTINEZ-MONTIEL, P12 ; GARCIA-MORAN, S8 ; SANCHEZ, M. C10 ; MENDOZA, J. L1 ; FERNANDEZ-BLANCO, I2 ; MERINO, O3 ; MARIN-JIMENEZ, I4 ; BARREIRO-DE ACOSTA, M5 ; SARO, C6 ; GARCIA-SANCHEZ, V7 ; GENTO, E8 ; BASTIDA, G9
[1] Hospital Clínico, Madrid, Spain
[2] Hospital La Paz, Madrid, Spain
[3] Hospital de Cruces, Bilbao, Spain
[4] Hospital Gregorio Marañón, Madrid, Spain
[5] Hospital Clínico, Santiago, Spain
[6] Hospital de Cabueñes, Gijon, Spain
[7] Hospital Reina Sofia, Cordoba, Spain
[8] Hospital General Yagüe, Burgos, Spain
[9] Hospital La Fe, Valencia, Spain
[10] Hospital La Princesa, Madrid, Spain
[11] Hospital Puerta de Hierro, Madrid, Spain
[12] Hospital 12 de Octubre, Madrid, Spain
[13] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain - Source
Alimentary pharmacology & therapeutics. 2011, Vol 33, Num 3, pp 340-348, 9 p ; ref : 26 ref
- ISSN
- 0269-2813
- Scientific domain
- Pharmacology drugs
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adalimumab Antipsoriasique Homme Immunodépresseur Immunomodulateur Infliximab Rectocolite ulcérohémorragique Traitement entretien Traitement induction Anti-TNF-alpha Anticorps monoclonal Anticytokine Cytokine Facteur nécrose tumorale α Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
- Keyword (en)
- Adalimumab Antipsoriatic agent Human Immunosuppressive agent Immunomodulator Infliximab Ulcerative colitis Maintenance treatment Induction treatment Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Cytokine Tumor necrosis factor α Inflammatory disease Digestive diseases Intestinal disease
- Keyword (es)
- Adalimumab Antipsoriásico Hombre Inmunodepresor Inmunomodulador Infliximab Rectocolitis ulcerohemorrágica Tratamiento sostén Tratamiento inductivo Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Citoquina Factor necrosis tumoral α Enfermedad inflamatoria Aparato digestivo patología Intestino patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02H Digestive system
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23699577
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1365-2036.2010.04531.x 
https://dx.doi.org/10.1111/j.1365-2036.2010.04531.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Alimentary pharmacology & therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"Aliment. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"340\";s:8:\"\u0000*\u0000epage\";s:3:\"348\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-2813\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAXONERA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ESTELLES, J\";i:1;s:13:\"GISBERT, J. P\";i:2;s:7:\"VERA, I\";i:3;s:19:\"MARTINEZ-MONTIEL, P\";i:4;s:15:\"GARCIA-MORAN, S\";i:5;s:13:\"SANCHEZ, M. C\";i:6;s:13:\"MENDOZA, J. L\";i:7;s:19:\"FERNANDEZ-BLANCO, I\";i:8;s:9:\"MERINO, O\";i:9;s:16:\"MARIN-JIMENEZ, I\";i:10;s:21:\"BARREIRO-DE ACOSTA, M\";i:11;s:7:\"SARO, C\";i:12;s:17:\"GARCIA-SANCHEZ, V\";i:13;s:8:\"GENTO, E\";i:14;s:10:\"BASTIDA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Alimentary pharmacology & therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"Aliment. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"340\";s:8:\"\u0000*\u0000epage\";s:3:\"348\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-2813\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAXONERA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ESTELLES, J\";i:1;s:13:\"GISBERT, J. P\";i:2;s:7:\"VERA, I\";i:3;s:19:\"MARTINEZ-MONTIEL, P\";i:4;s:15:\"GARCIA-MORAN, S\";i:5;s:13:\"SANCHEZ, M. C\";i:6;s:13:\"MENDOZA, J. L\";i:7;s:19:\"FERNANDEZ-BLANCO, I\";i:8;s:9:\"MERINO, O\";i:9;s:16:\"MARIN-JIMENEZ, I\";i:10;s:21:\"BARREIRO-DE ACOSTA, M\";i:11;s:7:\"SARO, C\";i:12;s:17:\"GARCIA-SANCHEZ, V\";i:13;s:8:\"GENTO, E\";i:14;s:10:\"BASTIDA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Alimentary pharmacology & therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"Aliment. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"340\";s:8:\"\u0000*\u0000epage\";s:3:\"348\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-2813\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAXONERA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ESTELLES, J\";i:1;s:13:\"GISBERT, J. P\";i:2;s:7:\"VERA, I\";i:3;s:19:\"MARTINEZ-MONTIEL, P\";i:4;s:15:\"GARCIA-MORAN, S\";i:5;s:13:\"SANCHEZ, M. C\";i:6;s:13:\"MENDOZA, J. L\";i:7;s:19:\"FERNANDEZ-BLANCO, I\";i:8;s:9:\"MERINO, O\";i:9;s:16:\"MARIN-JIMENEZ, I\";i:10;s:21:\"BARREIRO-DE ACOSTA, M\";i:11;s:7:\"SARO, C\";i:12;s:17:\"GARCIA-SANCHEZ, V\";i:13;s:8:\"GENTO, E\";i:14;s:10:\"BASTIDA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Alimentary pharmacology & therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"Aliment. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"340\";s:8:\"\u0000*\u0000epage\";s:3:\"348\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-2813\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAXONERA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ESTELLES, J\";i:1;s:13:\"GISBERT, J. P\";i:2;s:7:\"VERA, I\";i:3;s:19:\"MARTINEZ-MONTIEL, P\";i:4;s:15:\"GARCIA-MORAN, S\";i:5;s:13:\"SANCHEZ, M. C\";i:6;s:13:\"MENDOZA, J. L\";i:7;s:19:\"FERNANDEZ-BLANCO, I\";i:8;s:9:\"MERINO, O\";i:9;s:16:\"MARIN-JIMENEZ, I\";i:10;s:21:\"BARREIRO-DE ACOSTA, M\";i:11;s:7:\"SARO, C\";i:12;s:17:\"GARCIA-SANCHEZ, V\";i:13;s:8:\"GENTO, E\";i:14;s:10:\"BASTIDA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2036.2010.04531.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Alimentary pharmacology & therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"Aliment. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"340\";s:8:\"\u0000*\u0000epage\";s:3:\"348\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-2813\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAXONERA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"ESTELLES, J\";i:1;s:13:\"GISBERT, J. P\";i:2;s:7:\"VERA, I\";i:3;s:19:\"MARTINEZ-MONTIEL, P\";i:4;s:15:\"GARCIA-MORAN, S\";i:5;s:13:\"SANCHEZ, M. C\";i:6;s:13:\"MENDOZA, J. L\";i:7;s:19:\"FERNANDEZ-BLANCO, I\";i:8;s:9:\"MERINO, O\";i:9;s:16:\"MARIN-JIMENEZ, I\";i:10;s:21:\"BARREIRO-DE ACOSTA, M\";i:11;s:7:\"SARO, C\";i:12;s:17:\"GARCIA-SANCHEZ, V\";i:13;s:8:\"GENTO, E\";i:14;s:10:\"BASTIDA, G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
